title: Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion.
abstract: Endogenous opiate peptides acting pre- and post-synaptically in the dorsal horn of spinal cord inhibit transmission of nociceptive stimuli. We transfected neurons of the dorsal root ganglion in vivo by footpad inoculation with 30 microl (3 x 10(7) p.f.u.) of a replication-incompetent (ICP4-deleted) herpes simplex virus (HSV) vector with a cassette containing a portion of the human proenkephalin gene coding for 5 met- and 1 leu-enkephalin molecules under the control of the human cytomegalovirus immediate-early promoter (HCMV IEp) inserted in the HSV thymidine kinase (tk) locus. Vector-directed expression of enkephalin produced a significant antinociceptive effect measured by the formalin footpad test, that was most prominent in the delayed ("tonic") phase 20-70 min after the administration of formalin. The magnitude of the antinociceptive effect diminished over 4 weeks after transduction, but reinoculation of the vector reestablished the analgesic effect, without evidence for the development of tolerance. The antinociceptive effect was blocked completely by intrathecal naltrexone. These results suggest that gene therapy with an enkephalin-producing herpes-based vector may prove useful in the treatment of pain.
authors.affiliation: Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Goss
authors.forename: M
authors.initials: M
authors.lastname: Mata
authors.forename: W F
authors.initials: WF
authors.lastname: Goins
authors.forename: H H
authors.initials: HH
authors.lastname: Wu
authors.forename: J C
authors.initials: JC
authors.lastname: Glorioso
authors.forename: D J
authors.initials: DJ
authors.lastname: Fink
mesh_terms: D000698:Analgesia / Q000379:methods*; D000818:Animals; D004745:Enkephalins / Q000235:genetics* / Q000378:metabolism; D005557:Formaldehyde; D005727:Ganglia, Spinal / Q000378:metabolism*; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009271:Naltrexone / Q000494:pharmacology; D010147:Pain Measurement; D011498:Protein Precursors / Q000235:genetics* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D018139:Simplexvirus / Q000235:genetics*; D014162:Transfection
chemical_list: D004745:Enkephalins; D011498:Protein Precursors; C029992:proenkephalin; D005557:Formaldehyde; D009271:Naltrexone